紀錄類型 : 書目-語言資料,印刷品: 單行本
其他作者 : Kesharwani, Prashant,
出版項 : London, United Kingdom :Academic Press, an imprint of Elsevier,[2022]
面頁冊數 : 1 online resource (xxiii, 411 pages) :illustrations (chiefly color).
內容註 : Overcoming cancer drug resistance via nanomedicine-based combined drug delivery -- Overcoming the challenges of drug resistance through combination drug delivery approach -- Combination drug delivery approaches in ophthalmology -- Combination drug delivery system to enhance the transdermal drug delivery of bioactive molecules -- Combination drug delivery approaches in rheumatoid arthritis -- Aptamer-mediated drug delivery system for cardiovascular diseases -- Combination drug delivery approaches for viral infections -- Approaches and molecular tools for targeted drug delivery in malaria infected red blood cells -- Combination drug delivery approaches for tuberculosis -- Combination drug delivery approaches for cancer therapy -- Prodrug-based drug delivery approaches in cancer combination therapy -- Combination of anticancer drugs with microRNA as cancer therapeutics -- Nanotechnology-mediated combinational drug delivery approach for cancer therapy -- Premarket review and postmarket regulation of combination drug products -- Concluding remarks and future perspective of combination drug delivery systems.
標題 : Chemotherapy. -
標題 : Chemotherapy, Combination. -
標題 : Drug Therapy -
ISBN : 9780323858762
ISBN : 0323858767
LEADER 02476nam 2200349 i 4500
001 51132
003 NhCcYBP
005 20240202150008.5
006 m o d
007 cr un|---aucuu
008 220330t20222022enka ob 001 0 eng d
020 $a9780323858762$q(electronic book)
020 $a0323858767$q(electronic book)
020 $z9780323858731
020 $z0323858732
035 $aebs3051811
040 $aNhCcYBP$cNhCcYBP
041 $aeng
050 4$aRS199.5$b.C65 2022
082 04$a615/.6$223
245 00$aCombination drug delivery approach as an effective therapy for various diseases /$cedited by Prashant Kesharwani.
264 1$aLondon, United Kingdom :$bAcademic Press, an imprint of Elsevier,$c[2022]
264 4$c�2022
300 $a1 online resource (xxiii, 411 pages) :$billustrations (chiefly color).
336 $atext$btxt$2rdacontent
337 $acomputer$bc$2rdamedia
338 $aonline resource$bcr$2rdacarrier
504 $aIncludes bibliographical references and index.
505 0 $aOvercoming cancer drug resistance via nanomedicine-based combined drug delivery -- Overcoming the challenges of drug resistance through combination drug delivery approach -- Combination drug delivery approaches in ophthalmology -- Combination drug delivery system to enhance the transdermal drug delivery of bioactive molecules -- Combination drug delivery approaches in rheumatoid arthritis -- Aptamer-mediated drug delivery system for cardiovascular diseases -- Combination drug delivery approaches for viral infections -- Approaches and molecular tools for targeted drug delivery in malaria infected red blood cells -- Combination drug delivery approaches for tuberculosis -- Combination drug delivery approaches for cancer therapy -- Prodrug-based drug delivery approaches in cancer combination therapy -- Combination of anticancer drugs with microRNA as cancer therapeutics -- Nanotechnology-mediated combinational drug delivery approach for cancer therapy -- Premarket review and postmarket regulation of combination drug products -- Concluding remarks and future perspective of combination drug delivery systems.
533 $aElectronic reproduction.$bIpswich, MA$nAvailable via World Wide Web.
588 0 $aOnline resource; title from digital title page.
650 0$aDrug delivery systems.$388034
650 0$aChemotherapy.$327503
650 0$aChemotherapy, Combination.$397713
650 2$aDrug Delivery Systems$311940
650 2$aDrug Therapy$311998
700 1 $aKesharwani, Prashant,$eeditor.$389655
710 2 $aEBSCOhost$387894
776 08$cOriginal$z0323858732$z9780323858731
856 40$uhttps://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=3051811$zClick to View (限總院院內)